DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Thyrocare Technologies Limited — Press Release

NSE 1 hr ago·29 Oct 2026, 10:39 am

Thyrocare Technologies

Thyrocare Technologies has informed stock exchanges about the release of its unaudited financial results for the quarter and half-year ended September 30, 2026. This update provides investors with an early look at the company's operational performance and financial health for the period.

This announcement is significant for investors as it offers transparency into Thyrocare's recent business trajectory. By reviewing these figures, stakeholders can assess the company's growth momentum and operational efficiency ahead of the official financial disclosures.

Investors should monitor the specific details within the release, particularly revenue growth and operational metrics. Keeping an eye on these figures will help gauge the company's current standing and future outlook in the diagnostics sector.